Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine premedication and sevoflurane concentration for tracheal intubation in children
ACTRN12613000679785Phase 4Completed
- Sponsor
- Yusheng Pharmaceutical
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and sevoflurane, sponsored by Yusheng Pharmaceutical. Primary endpoint: Minimum alveolar concentration of sevoflurane for tracheal intubation. Started Jul 2013; status: completed.
02
Drugs
dexmedetomidinesevoflurane
Beyond the preview
Go deeper on ACTRN12613000679785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000679785.